The landscape of driver mutations in cutaneous squamous cell carcinoma

Abstract Cutaneous squamous cell carcinoma is a form of skin cancer originating from keratinocytes in the skin. It is the second most common type of cancer and is responsible for an estimated 8000 deaths per year in the United States. Compared to other cancer subtypes with similar incidences and dea...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Darwin Chang, A. Hunter Shain
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Acceso en línea:https://doaj.org/article/bab85fd9a5dc44c494d95b0c9848c502
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bab85fd9a5dc44c494d95b0c9848c502
record_format dspace
spelling oai:doaj.org-article:bab85fd9a5dc44c494d95b0c9848c5022021-12-02T17:01:16ZThe landscape of driver mutations in cutaneous squamous cell carcinoma10.1038/s41525-021-00226-42056-7944https://doaj.org/article/bab85fd9a5dc44c494d95b0c9848c5022021-07-01T00:00:00Zhttps://doi.org/10.1038/s41525-021-00226-4https://doaj.org/toc/2056-7944Abstract Cutaneous squamous cell carcinoma is a form of skin cancer originating from keratinocytes in the skin. It is the second most common type of cancer and is responsible for an estimated 8000 deaths per year in the United States. Compared to other cancer subtypes with similar incidences and death tolls, our understanding of the somatic mutations driving cutaneous squamous cell carcinoma is limited. The main challenge is that these tumors have high mutation burdens, primarily a consequence of UV-radiation-induced DNA damage from sunlight, making it difficult to distinguish driver mutations from passenger mutations. We overcame this challenge by performing a meta-analysis of publicly available sequencing data covering 105 tumors from 10 different studies. Moreover, we eliminated tumors with issues, such as low neoplastic cell content, and from the tumors that passed quality control, we utilized multiple strategies to reveal genes under selection. In total, we nominated 30 cancer genes. Among the more novel genes, mutations frequently affected EP300, PBRM1, USP28, and CHUK. Collectively, mutations in the NOTCH and p53 pathways were ubiquitous, and to a lesser extent, mutations affected genes in the Hippo pathway, genes in the Ras/MAPK/PI3K pathway, genes critical for cell-cycle checkpoint control, and genes encoding chromatin remodeling factors. Taken together, our study provides a catalog of driver genes in cutaneous squamous cell carcinoma, offering points of therapeutic intervention and insights into the biology of cutaneous squamous cell carcinoma.Darwin ChangA. Hunter ShainNature PortfolioarticleMedicineRGeneticsQH426-470ENnpj Genomic Medicine, Vol 6, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Genetics
QH426-470
spellingShingle Medicine
R
Genetics
QH426-470
Darwin Chang
A. Hunter Shain
The landscape of driver mutations in cutaneous squamous cell carcinoma
description Abstract Cutaneous squamous cell carcinoma is a form of skin cancer originating from keratinocytes in the skin. It is the second most common type of cancer and is responsible for an estimated 8000 deaths per year in the United States. Compared to other cancer subtypes with similar incidences and death tolls, our understanding of the somatic mutations driving cutaneous squamous cell carcinoma is limited. The main challenge is that these tumors have high mutation burdens, primarily a consequence of UV-radiation-induced DNA damage from sunlight, making it difficult to distinguish driver mutations from passenger mutations. We overcame this challenge by performing a meta-analysis of publicly available sequencing data covering 105 tumors from 10 different studies. Moreover, we eliminated tumors with issues, such as low neoplastic cell content, and from the tumors that passed quality control, we utilized multiple strategies to reveal genes under selection. In total, we nominated 30 cancer genes. Among the more novel genes, mutations frequently affected EP300, PBRM1, USP28, and CHUK. Collectively, mutations in the NOTCH and p53 pathways were ubiquitous, and to a lesser extent, mutations affected genes in the Hippo pathway, genes in the Ras/MAPK/PI3K pathway, genes critical for cell-cycle checkpoint control, and genes encoding chromatin remodeling factors. Taken together, our study provides a catalog of driver genes in cutaneous squamous cell carcinoma, offering points of therapeutic intervention and insights into the biology of cutaneous squamous cell carcinoma.
format article
author Darwin Chang
A. Hunter Shain
author_facet Darwin Chang
A. Hunter Shain
author_sort Darwin Chang
title The landscape of driver mutations in cutaneous squamous cell carcinoma
title_short The landscape of driver mutations in cutaneous squamous cell carcinoma
title_full The landscape of driver mutations in cutaneous squamous cell carcinoma
title_fullStr The landscape of driver mutations in cutaneous squamous cell carcinoma
title_full_unstemmed The landscape of driver mutations in cutaneous squamous cell carcinoma
title_sort landscape of driver mutations in cutaneous squamous cell carcinoma
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/bab85fd9a5dc44c494d95b0c9848c502
work_keys_str_mv AT darwinchang thelandscapeofdrivermutationsincutaneoussquamouscellcarcinoma
AT ahuntershain thelandscapeofdrivermutationsincutaneoussquamouscellcarcinoma
AT darwinchang landscapeofdrivermutationsincutaneoussquamouscellcarcinoma
AT ahuntershain landscapeofdrivermutationsincutaneoussquamouscellcarcinoma
_version_ 1718382234393640960